PriMo Biotechnology Equate 2026 IPO Target to build radiophautical education strategy
PMO Biotechnology Co. , Ltd. PriMo biotechnology assured capital and target 2026 IPO To increase world radiophorm's strategic building and innovation of drugs are Taiwan, July 02, 2025 (2025) With all of the capital, lift its path to leaders in…

